Type 2 diabetes mellitus (T2DM) is a disease characterized by non-autoimmune heterogeneous progressive pancreatic islet β-cell insulin underproduction [1], which often occurs in the presence of insulin resistance (IR) and the metabolic syndrome (MS) [2,3]. Here, INS is linked to Insulin resistance.